Close

TherapeuticsMD (TXMD) Misses Q2 EPS by 5c

August 6, 2015 5:57 PM EDT

TherapeuticsMD (NYSE: TXMD) reported Q2 EPS of ($0.16), $0.05 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $4.8 million versus the consensus estimate of $4.65 million.

For earnings history and earnings-related data on TherapeuticsMD (TXMD) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings